| Aminoquinolines against coronavirus disease 2019 (COVID-19): chloroquine or hydroxychloroquine Z Sahraei, M Shabani, S Shokouhi, A Saffaei Int J Antimicrob Agents 55 (4), 105945, 2020 | 271 | 2020 |
| Role of interferon therapy in severe COVID-19: the COVIFERON randomized controlled trial I Alavi Darazam, S Shokouhi, MA Pourhoseingholi, SS Naghibi Irvani, ... Scientific reports 11 (1), 8059, 2021 | 129 | 2021 |
| Bacteriuria by extended-spectrum Beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: isolates in a governmental hospital in South of Tehran, Iran M Aminzadeh, Z., Sadat Kashi, M., Shabani Iranian journal of kidney diseases 2 (4), 197-200, 2008 | 86* | 2008 |
| Umifenovir in hospitalized moderate to severe COVID-19 patients: A randomized clinical trial IA Darazam, S Shokouhi, M Mardani, MA Pourhoseingholi, MM Rabiei, ... International Immunopharmacology 99, 107969, 2021 | 35 | 2021 |
| Evaluation of the effect of sofosbuvir and daclatasvir in hospitalized COVID-19 patients: a randomized double-blind clinical trial (DISCOVER) S Mobarak, M Salasi, A Hormati, J Khodadadi, M Ziaee, F Abedi, ... Journal of Antimicrobial Chemotherapy 77 (3), 758-766, 2022 | 22 | 2022 |
| Efficacy of hemoperfusion in severe and critical cases of COVID-19 I Alavi Darazam, M Kazempour, MA Pourhoseingholi, F Hatami, ... Blood purification 52 (1), 8-16, 2023 | 19 | 2023 |
| An investigation into the beneficial effects of high-dose interferon beta 1-a, compared to low-dose interferon beta 1-a in severe COVID-19: The COVIFERON II randomized … IA Darazam, F Hatami, MM Rabiei, MA Pourhoseingholi, M Shabani, ... International Immunopharmacology 99, 107916, 2021 | 14 | 2021 |
| Vancomycin and five broad-spectrum antibiotic utilization evaluation in an educational medical center in one year SD Shoaei, A Bagherzadeh, M Haghighi, M Shabani Journal of Pharmaceutical Care, 154-161, 2014 | 12 | 2014 |
| Prevalence of Methicilin-Resistance-Staphylococcus-Aureus in different wards of Imam Hossein Hospital in Tehran, in 2007-2008. B Razin, M Shabani, M Nabavi, N Taghavi, M Haghighi, M Foroumand Pejouhandeh 14 (5), 2010 | 10 | 2010 |
| An investigation into the beneficial effects of high-dose interferon beta 1-a, compared to low-dose interferon beta 1-a (the base therapeutic regimen) in moderate to severe … I Alavi Darazam, F Hatami, MM Rabiei, MA Pourhoseingholi, O Moradi, ... Trials 21, 1-3, 2020 | 9 | 2020 |
| Iranian society of cardiac surgeons position statement for the treatment of patients in need of cardiac surgery in the COVID-19 pandemic period (Version I) E Asdaghpour, R Baghaei, N Jalilifar, H Radmehr, M Shirzad, ... Multidisciplinary Cardiovascular Annals 11 (1), 2020 | 8 | 2020 |
| Evaluation of the prophylactic effect of hydroxychloroquine on people in close-contact with patients with COVID-19 M Shabani, M Totonchi, O Rezaeimirghaed, L Gachkar, M Hajiesmaeili, ... Pulmonary Pharmacology & Therapeutics 70, 102069, 2021 | 6 | 2021 |
| Study of the effects of interferon β− 1a on hospitalized patients with COVID‐19: SBMU Taskforce on the COVIFERON study M Fallahzadeh, MA Pourhoseingholi, MG Boroujeni, S Besharati, ... Journal of Medical Virology 94 (4), 1488-1493, 2022 | 5 | 2022 |
| Clinical and Epidemiological Characteristics of Postdischarge Patients With COVID-19 in Tehran, Iran:Protocol for a Prospective Cohort Study (Tele-COVID-19 Study) MD Laya Jalilian Khave 1*, MD Mohammad Vahidi1*, MD Dorsa Shirini1, ... JMIR RESEARCH PROTOCOLS 10 (2), 2021 | 5 | 2021 |
| Investigation of the Frequency of Foodborne Botulism in Patients Referred to Loghman Hospital in Tehran City, Iran, From 2008 to 2019 MMS Dallal, F Najar, AK Shabani, K Ezoji, M Shabani, MRM Khorasan, ... International Journal of Medical Toxicology and Forensic Medicine 10 (2 …, 2020 | 5 | 2020 |
| Cutaneous necrotic lesion: A wonderful delay adverse effect of interferon beta‐1b injection for multiple sclerosis treatment N Mozafari, A Saffaei, M Alizadeh, M Shabani Journal of Cosmetic Dermatology 19 (4), 951-953, 2020 | 5 | 2020 |
| A challenge between central nervous system infection and Lead toxicity: opioid case reports from Iran M Shabani, M Nasiri, Z Aminzadeh, HH Moghaddam Iranian Journal of Medical Sciences 44 (2), 168, 2019 | 5 | 2019 |
| Clinical and Epidemiological Characteristics of Coronavirus Disease 2019 in Iran: A hospital-based observational study IA Darazam, S Besharati, M Shabani, S Shokouhi, M Fallahzadeh, ... Tanaffos 20 (2), 156, 2021 | 4 | 2021 |
| Early recovery of botulism: one decade of experience IAD Firouze Hatami, Shervin Shokouhi, Masoud Mardani, Minoush Shabani, Latif ... Clinical Toxicology, 2020 | 4* | 2020 |
| Aminoquinolines Against Corona-virus Disease 2019 (COVID-19): Chloroquine or Hydroxychloroquine Corresponding Author: Beheshti University of Medical Sciences, Tehran, Iran … SP Zahra, M Shabani Int J Antimicrob Agents [Internet] 2019, 105945, 2020 | 4 | 2020 |
Zohreh AminzadehProfessor of MedicineVerified email at sbmu.ac.ir
